Maestros Electronics & Telecommun. Systems Ltd
Incorporated in 2010, Maestros Electronics & Telecommunications Systems Ltd is in the business of Electronics & Instrumentation (E&T) and Telemedicine[1]
- Market Cap ₹ 99.7 Cr.
- Current Price ₹ 181
- High / Low ₹ 262 / 91.5
- Stock P/E 17.8
- Book Value ₹ 59.5
- Dividend Yield 0.00 %
- ROCE 23.3 %
- ROE 17.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Debtor days have improved from 235 to 172 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.3% over last 3 years.
- Earnings include an other income of Rs.2.26 Cr.
- Company has high debtors of 172 days.
- Promoter holding has decreased over last 3 years: -8.22%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10.23 | 14.30 | 16.54 | 11.04 | 12.86 | 9.22 | 9.53 | 13.54 | 47.55 | 11.15 | 24.60 | 33.29 | 35.21 | |
9.50 | 13.30 | 15.09 | 10.27 | 11.38 | 9.47 | 8.87 | 11.94 | 39.06 | 10.11 | 20.93 | 27.37 | 28.63 | |
Operating Profit | 0.73 | 1.00 | 1.45 | 0.77 | 1.48 | -0.25 | 0.66 | 1.60 | 8.49 | 1.04 | 3.67 | 5.92 | 6.58 |
OPM % | 7.14% | 6.99% | 8.77% | 6.97% | 11.51% | -2.71% | 6.93% | 11.82% | 17.85% | 9.33% | 14.92% | 17.78% | 18.69% |
0.08 | 0.39 | 0.55 | 0.84 | 0.52 | 0.82 | 0.58 | 0.47 | 0.96 | 1.48 | 1.26 | 2.24 | 2.26 | |
Interest | 0.12 | 0.32 | 0.42 | 0.32 | 0.37 | 0.33 | 0.31 | 1.10 | 1.37 | 0.46 | 0.52 | 0.80 | 0.60 |
Depreciation | 0.27 | 0.39 | 0.56 | 0.65 | 0.60 | 0.44 | 0.46 | 0.45 | 0.36 | 0.37 | 0.39 | 0.45 | 0.43 |
Profit before tax | 0.42 | 0.68 | 1.02 | 0.64 | 1.03 | -0.20 | 0.47 | 0.52 | 7.72 | 1.69 | 4.02 | 6.91 | 7.81 |
Tax % | 30.95% | 23.53% | 32.35% | 31.25% | 32.04% | 25.00% | 25.53% | 32.69% | 26.94% | 25.44% | 25.87% | 28.51% | |
0.29 | 0.52 | 0.69 | 0.45 | 0.70 | -0.25 | 0.34 | 0.35 | 5.64 | 1.25 | 2.98 | 4.94 | 5.59 | |
EPS in Rs | 0.88 | 1.59 | 1.88 | 1.13 | 1.62 | -0.53 | 0.69 | 0.67 | 10.24 | 2.27 | 5.41 | 8.97 | 10.14 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 22.04% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 28% |
3 Years: | -11% |
TTM: | 23% |
Compounded Profit Growth | |
---|---|
10 Years: | 25% |
5 Years: | 71% |
3 Years: | -4% |
TTM: | 49% |
Stock Price CAGR | |
---|---|
10 Years: | 22% |
5 Years: | 24% |
3 Years: | 49% |
1 Year: | 54% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 14% |
3 Years: | 12% |
Last Year: | 18% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.28 | 3.28 | 3.68 | 3.97 | 4.31 | 4.71 | 4.94 | 5.24 | 5.51 | 5.51 | 5.51 | 5.51 | 5.51 |
Reserves | 4.55 | 5.07 | 5.97 | 7.41 | 8.06 | 8.24 | 9.41 | 10.12 | 16.08 | 17.05 | 20.06 | 25.02 | 27.28 |
4.27 | 3.53 | 3.99 | 2.59 | 3.88 | 2.61 | 2.56 | 8.23 | 2.10 | 2.10 | 4.79 | 5.35 | 2.39 | |
4.40 | 5.12 | 6.00 | 6.87 | 5.87 | 5.98 | 5.17 | 16.90 | 34.39 | 29.43 | 11.99 | 21.39 | 18.36 | |
Total Liabilities | 16.50 | 17.00 | 19.64 | 20.84 | 22.12 | 21.54 | 22.08 | 40.49 | 58.08 | 54.09 | 42.35 | 57.27 | 53.54 |
3.49 | 6.56 | 6.38 | 5.89 | 8.44 | 8.09 | 8.22 | 8.01 | 7.89 | 7.85 | 8.46 | 8.21 | 8.55 | |
CWIP | 2.31 | 0.00 | 1.36 | 2.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.71 | 4.06 |
Investments | 0.00 | 0.00 | 0.14 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
10.70 | 10.44 | 11.76 | 11.99 | 13.68 | 13.45 | 13.86 | 32.48 | 50.19 | 46.24 | 33.89 | 45.35 | 40.93 | |
Total Assets | 16.50 | 17.00 | 19.64 | 20.84 | 22.12 | 21.54 | 22.08 | 40.49 | 58.08 | 54.09 | 42.35 | 57.27 | 53.54 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.87 | 3.31 | 1.83 | 1.00 | -1.39 | -1.91 | -0.85 | -3.55 | 27.69 | -8.47 | -5.76 | 7.25 | |
-0.89 | -5.70 | -1.33 | -1.48 | 0.26 | 0.56 | 0.27 | 1.99 | 1.95 | 0.91 | 3.55 | -7.02 | |
1.92 | 0.09 | 0.63 | 0.47 | 0.68 | 0.47 | 0.23 | 2.09 | -4.50 | -0.74 | 1.65 | -0.24 | |
Net Cash Flow | 2.90 | -2.30 | 1.12 | -0.02 | -0.45 | -0.88 | -0.36 | 0.53 | 25.15 | -8.30 | -0.56 | -0.01 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 148.78 | 78.62 | 73.71 | 105.80 | 96.78 | 91.45 | 107.24 | 83.30 | 94.49 | 384.64 | 149.12 | 172.36 |
Inventory Days | 32.55 | 7.19 | 20.24 | 34.11 | 83.72 | 172.85 | 221.61 | 524.81 | 179.81 | 359.80 | ||
Days Payable | 130.77 | 113.16 | 137.12 | 309.85 | 199.24 | 318.37 | 221.61 | 153.48 | 137.38 | 236.83 | ||
Cash Conversion Cycle | 50.56 | -27.36 | -43.17 | -169.94 | -18.74 | -54.07 | 107.24 | 454.62 | 94.49 | 384.64 | 191.54 | 295.33 |
Working Capital Days | 26.40 | -24.76 | -32.88 | -82.98 | 2.84 | -5.94 | 58.22 | 234.26 | -123.13 | -220.31 | 72.41 | 22.26 |
ROCE % | 5.34% | 8.34% | 11.29% | 6.95% | 9.27% | 0.82% | 4.80% | 8.00% | 38.45% | 8.98% | 16.32% | 23.28% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
7 Feb - Received purchase order for cardiac monitors worth Rs. 6.49 Crores.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
6 Feb - Read with schedule III of SEBI(LODR) 2015 please find enclosed copy of newspaper publication dated February 06, 2025 in the following newspaper with respect to …
-
Integrated Filing (Financial)
5 Feb - Submission of unaudited financial results for Q4 2024.
-
Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.
4 Feb - Board approved unaudited financial results for Q3 2024.
-
Board Meeting Outcome for Board Meeting Outcome Under Regulation 30 & 33 Of SEBI(LODR)Reg 2015 For The Board Meeting Held On February 04, 2025
4 Feb - Board approved unaudited financial results for Q3 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
Business Overview:[1]
Company is a design, development and manufacturing company which creates
products and services for financial inclusion, cardiology, gynecology, critical care patient
and diseases management in medicine. It specializes in Medical device manufacturing, Telemedicine and Healthcare Solutions and Business Automation (Banking and Micro finance, financial inclusion, PDS automation)